Jazz Pharmaceuticals plc — Director's Dealing 2010

Mar 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-03-08

Reporting Person: MYERS ROBERT M (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-08	Common Stock	S	200	$11.54	Disposed	152723	Direct
2010-03-08	Common Stock	S	4826	$11.53	Disposed	147897	Direct
2010-03-08	Common Stock	S	2050	$11.48	Disposed	145847	Direct
2010-03-08	Common Stock	S	3293	$11.50	Disposed	142554	Direct
2010-03-09	Common Stock	S	50	$11.55	Disposed	142504	Direct
2010-03-09	Common Stock	S	4581	$11.36	Disposed	137923	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-08	Option (right to buy)	$11.48	A	75000	Acquired	2020-03-07	Common Stock (75000)	Direct

Footnotes

F1: The options vest over four years measured from the vesting commencement date, March 8, 2010, with 1/4th vesting on the first anniversary of the vesting commencment date and the remainder vesting in 36 equal monthly installments thereafter.